UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Glucocorticoid-induced osteoporosis: 2019 concise clinical review

Osteoporosis international, 2019-06, Vol.30 (6), p.1145-1156

2019

Volltextzugriff (PDF)

The clinician’s guide to prevention and treatment of osteoporosis

Osteoporosis international, 2022-10, Vol.33 (10), p.2049-2102

2022

Volltextzugriff (PDF)

Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures

Osteoporosis international, 2020-01, Vol.31 (1), p.1-12

2020

Volltextzugriff (PDF)

Hip fracture trends in the United States, 2002 to 2015

Osteoporosis international, 2018-03, Vol.29 (3), p.717-722

2018

Volltextzugriff (PDF)

EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases

Annals of the rheumatic diseases, 2007-12, Vol.66 (12), p.1560-1567

2007

Volltextzugriff (PDF)

Gout epidemiology: results from the UK General Practice Research Database, 1990–1999

Annals of the rheumatic diseases, 2005-02, Vol.64 (2), p.267-272

2005

Volltextzugriff (PDF)

SP0012 What to do After 5 Years of Treatment of Osteoporosis?

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.4-4

Saag, K.

2015

Volltextzugriff (PDF)

The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group

Osteoporosis international, 2014-05, Vol.25 (5), p.1439-1443

2014

Volltextzugriff (PDF)

The impact of the new National Bone Health Alliance (NBHA) diagnostic criteria on the prevalence of osteoporosis in the USA

Osteoporosis international, 2017-04, Vol.28 (4), p.1225-1232

2017

Volltextzugriff (PDF)

Treat-to-target (T2T) recommendations for gout

Annals of the rheumatic diseases, 2017-04, Vol.76 (4), p.632-638

2017

Volltextzugriff (PDF)

SP0090 Similarities and Differences in RA Treatment Guidelines: the US View

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.24-24

Saag, K.

2014

Volltextzugriff (PDF)

Correction to: The clinician’s guide to prevention and treatment of osteoporosis

Osteoporosis international, 2022-10, Vol.33 (10), p.2243-2243

2022

Volltextzugriff (PDF)

Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data

Annals of the Rheumatic Diseases, 2006-03, Vol.65 (3), p.285-293

2006

Volltextzugriff (PDF)

Risk of hip fracture after bisphosphonate discontinuation: implications for a drug holiday

Osteoporosis international, 2008-11, Vol.19 (11), p.1613-1620, Article 1613

2008

Volltextzugriff (PDF)

Real-world bone turnover marker use: impact on treatment decisions and fracture

Osteoporosis international, 2021-05, Vol.32 (5), p.831-840

2021

Volltextzugriff (PDF)

Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women

Bone (New York, N.Y.), 2019-06, Vol.123, p.191-195

2019

Volltextzugriff (PDF)

Glucocorticoid exposure and fracture risk in patients with new-onset rheumatoid arthritis

Osteoporosis international, 2016-11, Vol.27 (11), p.3239-3249

2016

Volltextzugriff (PDF)

The impact of the new National Bone Health Alliance (NBHA) diagnostic criteria on the prevalence of osteoporosis in the United States: supplementary presentation

Osteoporosis international, 2017-11, Vol.28 (11), p.3283-3284

2017

Volltextzugriff (PDF)

Risk of Hospitalized Bacterial Infections Associated With Biologic Treatment Among US Veterans With Rheumatoid Arthritis

Arthritis care & research (2010), 2014-07, Vol.66 (7), p.990-997

2014

Volltextzugriff (PDF)

The epidemiology of glucocorticoid-associated adverse events

Current opinion in rheumatology, 2008-03, Vol.20 (2), p.131-137

2008

Volltextzugriff (PDF)

POS1122 PRELIMINARY FINDINGS OF THE PROTECT CLINICAL TRIAL: PEGLOTICASE EFFICACY AND SAFETY IN KIDNEY TRANSPLANT RECIPIENTS

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.840-840

2021

Volltextzugriff (PDF)

Vertebroplasty and kyphoplasty are associated with an increased risk of secondary vertebral compression fractures: a population-based cohort study

Osteoporosis international, 2009-05, Vol.20 (5), p.819-826

2009

Volltextzugriff (PDF)

POS1148 RISK FACTORS FOR POLYARTICULAR GOUT FLARES—ANALYSIS OF A LONGITUDINAL ONLINE GOUT FOLLOW-UP STUDY

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.853-853

2021

Volltextzugriff (PDF)

Patient and rheumatologist perspectives on glucocorticoids: an exercise to improve the implementation of the European League Against Rheumatism (EULAR) recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases

Annals of the rheumatic diseases, 2010-06, Vol.69 (6), p.1015-1021

2010

Volltextzugriff (PDF)

1 – 25 von 519

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieArthritis Care And Research

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(489)
Mit Volltextzugriff
(417)

Publikationsform

Sprache

Englisch
(519)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Glucocorticoid-induced osteoporosis: 2019 concise clinical review

The clinician’s guide to prevention and treatment of osteoporosis

Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures

Hip fracture trends in the United States, 2002 to 2015

EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases

Gout epidemiology: results from the UK General Practice Research Database, 1990–1999

SP0012 What to do After 5 Years of Treatment of Osteoporosis?

The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group

The impact of the new National Bone Health Alliance (NBHA) diagnostic criteria on the prevalence of osteoporosis in the USA

Treat-to-target (T2T) recommendations for gout

SP0090 Similarities and Differences in RA Treatment Guidelines: the US View

Correction to: The clinician’s guide to prevention and treatment of osteoporosis

Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data

Risk of hip fracture after bisphosphonate discontinuation: implications for a drug holiday

Real-world bone turnover marker use: impact on treatment decisions and fracture

Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women

Glucocorticoid exposure and fracture risk in patients with new-onset rheumatoid arthritis

The impact of the new National Bone Health Alliance (NBHA) diagnostic criteria on the prevalence of osteoporosis in the United States: supplementary presentation

Risk of Hospitalized Bacterial Infections Associated With Biologic Treatment Among US Veterans With Rheumatoid Arthritis

The epidemiology of glucocorticoid-associated adverse events

POS1122 PRELIMINARY FINDINGS OF THE PROTECT CLINICAL TRIAL: PEGLOTICASE EFFICACY AND SAFETY IN KIDNEY TRANSPLANT RECIPIENTS

Vertebroplasty and kyphoplasty are associated with an increased risk of secondary vertebral compression fractures: a population-based cohort study

POS1148 RISK FACTORS FOR POLYARTICULAR GOUT FLARES—ANALYSIS OF A LONGITUDINAL ONLINE GOUT FOLLOW-UP STUDY

Patient and rheumatologist perspectives on glucocorticoids: an exercise to improve the implementation of the European League Against Rheumatism (EULAR) recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases

Aktive Filter

Suchergebnisse filtern